[Study of surgery combined with 125I brachytherapy for adenoid cystic carcinoma of oral and maxillofacial region].

C Li, Shih‐Hao Liu, Lei Zheng, Mengqian Huang, Yan Shi, Xianli Lv, Jiayu Zhang, Jun ZhangPubMed 2019 · DOI

Abstract

<sub>125</sub>I brachytherapy conducted as an adjuvant therapy postoperatively of ACC of oral and maxillofacial region can acquire satisfactory localregional control, distant metastasis-free survival, disease-free survival and overall survival. Tumors are prone to recur on the older patients. Patients having advanced tumor stage or tumor located in the nasal cavity or sinuses will suffer lower survival rates.
BibTeX
@inproceedings{li2019study,
  author = {C Li and Shih‐Hao Liu and Lei Zheng and Mengqian Huang and Yan Shi and Xianli Lv and Jiayu Zhang and Jun Zhang},
  title = {{[Study of surgery combined with <sub>125</sub>I brachytherapy for adenoid cystic carcinoma of oral and maxillofacial region].}},
  booktitle = {PubMed},
  year = {2019},
  doi = {10.19723/j.issn.1671-167x.2019.01.009},
}

Loading related content...

Figure